Generics - Apotex


Current filters:


Popular Filters

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex


US generics drug major Mylan says that the US District Court for the District of New Jersey granted its…


AstraZeneca wins damages from Apotex

AstraZeneca wins damages from Apotex


Anglo-Swedish drug major AstraZeneca this morning said it welcomed the US District Court for the Southern…

ApotexAstraZenecaFinancialGastro-intestinalsGenericsNexium I.V.North AmericaPatentsPrilosec

US appeals court reverses paroxetine order in favor of Mylan


US generic drugmaker Mylan (Nasdaq: MYL) today (July 23) announced that the US Third Circuit Court of…

ApotexGenericsGlaxoSmithKlineLegalMylan LaboratoriesNeurologicalNorth AmericaparoxetinePatentsPaxil

New Zealand consults on amiloride, perindopril and trandolapril funding


New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to fund new…


Nuvo Research in patent settlement over Pennsaid


Canada's Nuvo Research (TSX: NRI) says it has entered into a settlement agreement with Apotex Inc and…

Anti-Arthritics/RheumaticsApotexGenericsMallinckrodtNorth AmericaNuvo ResearchPatentsPennsaid

FDA approves first generics of Roche osteo drug Boniva


The US Food and Drug Administration yesterday approved the first generic versions of Boniva (ibandronate)…

Anti-Arthritics/RheumaticsApotexBonivaGenericsMylan LaboratoriesNorth AmericaOrchid HealthcareRegulationRoche

Sanofi fourth-quarter in line with forecasts; collects damages


French drug major Sanofi (Euronext: SAN) this morning reported 8.8% growth in fourth-quarter 2011 sales…

ApotexBristol-Myers SquibbFinancialGenericsLegalPatentsPharmaceuticalPlavix

Back to top